Harrow Health (HROW) Misses Q1 EPS by 39c ; Offers Guidance

Harrow Health (NASDAQ: HROW) reported Q1 EPS of ($0.74), $0.39 worse than the analyst estimate of ($0.35). Revenue for the quarter came in at $44.2 million versus the consensus estimate of $52.55 million.

GUIDANCE:

Harrow Health sees FY2026 revenue of $350-365 million, versus the consensus of $351.3 million.

For earnings history and earnings-related data on Harrow Health (HROW) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Metalla Royalty & Streaming Ltd. (MTA) Reports In-Line Q2 EPS
• KULR Technology Group (KULR) Misses Q2 EPS by 39c